Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 Eve & Co IncProbiotecDepomedDelta 9 CannabisBiosyent
SymbolCVE:EVEASX:PBPNYSE:ASRTCVE:NINECVE:RX
Price Information
Current PriceC$0.26A$1.90$1.37C$1.03C$6.05
52 Week RangeStrong BuyN/AHoldN/ABuy
Analyst Ratings
Consensus RecommendationStrong BuyN/AHoldN/ABuy
Consensus Price TargetC$1.08N/A$3.00C$2.20C$6.75
% Upside from Price Target315.38% upsideN/A118.98% upside113.59% upside11.57% upside
Trade Information
Market CapC$70.61 million$113.77 million$85.57 millionC$89.36 millionC$82.76 million
BetaN/AN/AN/AN/AN/A
Average Volume955,294N/A997,791117,3008,549
Sales & Book Value
Annual RevenueC$413,711.00$79.09 millionN/AC$12.87 millionC$20.81 million
Price / Sales167.461.44N/A6.944.00
CashflowC$0.05 per shareA$0.15 per shareN/AC$0.09 per shareC$1.45 per share
Price / Cash4.8212.59N/A11.914.17
Book ValueC$0.13 per shareA$0.83 per shareN/AC$0.53 per shareC$1.80 per share
Price / Book1.982.28N/A1.953.37
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSC($0.04)A$0.18N/AC$0.05C$0.32
Trailing P/E RatioN/A10.830.0019.0718.72
Forward P/E Ratio
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AA$0.04N/AN/AN/A
Dividend YieldN/A2.11%N/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/A22.86%N/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio29.35%61.62%N/A33.00%N/A
Current Ratio1.83%2.45%N/A4.44%8.61%
Quick Ratio0.77%1.44%N/A2.04%7.73%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
EmployeesN/AN/AN/A79N/A
Shares Outstanding266.47 million60.04 million64.83 million86.76 million13.77 million
Next Earnings DateN/AN/A11/14/2019 (Estimated)N/A11/20/2019 (Estimated)
OptionableNot OptionableNot OptionableOptionableOptionableNot Optionable
 Eve & Co IncProbiotecDepomedDelta 9 CannabisBiosyent

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel